Bio-Path Holdings, Inc. (BPTH)
OTCMKTS
· Delayed Price · Currency is USD
0.210
0.00 (0.00%)
Feb 18, 2025, 4:00 PM EST
Bio-Path Holdings Employees
Bio-Path Holdings had 10 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
10
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,051,300
Market Cap
796.78K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
Bio-Path Holdings News
- 7 days ago - ARMISTICE CAPITAL, LLC Acquires Significant Stake in Bio-Path Holdings Inc - GuruFocus
- 9 days ago - Bio-Path Holdings Provides Key Clinical Updates - GlobeNewsWire
- 10 days ago - Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid Leukemia - GlobeNewsWire
- 6 weeks ago - Bio-Path Holdings Provides 2025 Clinical and Operational Update - GlobeNewsWire
- 2 months ago - Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients Enhances Insulin Sensitivity - GlobeNewsWire
- 2 months ago - Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 24 - Newsfile Corp
- 2 months ago - Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients - GlobeNewsWire
- 3 months ago - Bio-Path Holdings, Inc. (BPTH) Q3 2024 Earnings Call Transcript - Seeking Alpha